Source: Peter Sullivan, THE HILL, 1/13/21


A coronavirus vaccine from Johnson & Johnson was found to be safe and to generate an immune response in early trials, promising signs as research continues. The results published Wednesday in The New England Journal of Medicine are from early-stage trials. The more conclusive results on the effectiveness of the vaccine are still to come in a phase three trial, which the company said Wednesday could be available soon, in "late January."

For more of this story, click here.